IL283931A - Administering sulcardine to treat severe atrial fibrillation - Google Patents

Administering sulcardine to treat severe atrial fibrillation

Info

Publication number
IL283931A
IL283931A IL283931A IL28393121A IL283931A IL 283931 A IL283931 A IL 283931A IL 283931 A IL283931 A IL 283931A IL 28393121 A IL28393121 A IL 28393121A IL 283931 A IL283931 A IL 283931A
Authority
IL
Israel
Prior art keywords
sulcardine
administration
treatment
atrial fibrillation
acute atrial
Prior art date
Application number
IL283931A
Other languages
English (en)
Hebrew (he)
Original Assignee
Huya Bioscience Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huya Bioscience Int Llc filed Critical Huya Bioscience Int Llc
Publication of IL283931A publication Critical patent/IL283931A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL283931A 2018-12-13 2021-06-13 Administering sulcardine to treat severe atrial fibrillation IL283931A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862779056P 2018-12-13 2018-12-13
US201962858324P 2019-06-06 2019-06-06
PCT/US2019/066003 WO2020123824A1 (en) 2018-12-13 2019-12-12 Sulcardine administration for treatment of acute atrial fibrillation

Publications (1)

Publication Number Publication Date
IL283931A true IL283931A (en) 2021-07-29

Family

ID=69165588

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283931A IL283931A (en) 2018-12-13 2021-06-13 Administering sulcardine to treat severe atrial fibrillation

Country Status (11)

Country Link
US (4) US11364223B2 (cg-RX-API-DMAC7.html)
EP (1) EP3893870A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022514537A (cg-RX-API-DMAC7.html)
KR (1) KR20210135990A (cg-RX-API-DMAC7.html)
CN (1) CN113453677A (cg-RX-API-DMAC7.html)
AU (1) AU2019397511B2 (cg-RX-API-DMAC7.html)
CA (1) CA3123078A1 (cg-RX-API-DMAC7.html)
IL (1) IL283931A (cg-RX-API-DMAC7.html)
MX (1) MX2021006933A (cg-RX-API-DMAC7.html)
WO (1) WO2020123824A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202104166B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR102405199B1 (ko) 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
US11813245B2 (en) * 2020-06-12 2023-11-14 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用
WO2026036095A1 (en) * 2024-08-08 2026-02-12 Huyabio International, Llc J-Tp PROTECTION

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
CN101484181B (zh) 2006-06-30 2012-12-26 希格马托罕见疾病公司 用于生产l-天门冬酰胺酶ⅱ的重组宿主
KR101491867B1 (ko) 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
WO2011062903A2 (en) 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011126811A2 (en) 2010-03-30 2011-10-13 Pfenex Inc. High level expression of recombinant toxin proteins
KR102092225B1 (ko) 2014-04-30 2020-03-23 주식회사 엘지화학 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
WO2016089782A1 (en) 2014-12-01 2016-06-09 Pfenex Inc. Fusion partners for peptide production
EP3302442B1 (en) 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
AU2017261372B2 (en) 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
AU2018212273B2 (en) 2017-01-26 2023-12-21 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR102405199B1 (ko) 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염

Also Published As

Publication number Publication date
AU2019397511A1 (en) 2021-07-22
US20220280480A1 (en) 2022-09-08
US20250302805A1 (en) 2025-10-02
US11364223B2 (en) 2022-06-21
CA3123078A1 (en) 2020-06-18
WO2020123824A1 (en) 2020-06-18
JP2022514537A (ja) 2022-02-14
EP3893870A1 (en) 2021-10-20
MX2021006933A (es) 2021-09-30
US12357611B2 (en) 2025-07-15
US11883380B2 (en) 2024-01-30
KR20210135990A (ko) 2021-11-16
US20200188357A1 (en) 2020-06-18
US20240115548A1 (en) 2024-04-11
CN113453677A (zh) 2021-09-28
ZA202104166B (en) 2023-11-29
AU2019397511B2 (en) 2025-08-21

Similar Documents

Publication Publication Date Title
IL275975B (en) Mapping of atrial fibrillation
EP3242605A4 (en) Angiogenic treatment of ischemic heart disease
EP3242709A4 (en) Cardiac stimulation of atrial-ventricle pathways and/or associated tissue
IL279260A (en) KDM1A inhibitors for the treatment of diseases
IL269083A (en) Methods for preventing and treating heart disease
EP3169259A4 (en) Cardiac cryolipolysis for the treatment of cardiac arrhythmia
PL3352745T3 (pl) Połączenie dofetylidu i meksyletyny w zapobieganiu i leczeniu migotania przedsionków
EP3260165A4 (en) Medical device for treating cardiac arrhythmia
IL275273A (en) An improved compound for the treatment of heart failure
PT3302523T (pt) Composição para o tratamento de lesões tecidulares
EP3185797A4 (en) Tissue protecting devices for treatment of congestive heart failure and other conditions
IL267047A (en) Catheters, systems and related methods for mapping, minimizing and treating cardiac fibrillation
IL263047B (en) Cardiac surgery cryoprobe
IL280243A (en) Compounds similar to 17beta-heterocyclyl-digitalis for the treatment of heart failure
EP3503965B8 (en) Treatment of cardiac dysfunction
PT3833378T (pt) Tratamento de verrugas
PT3713572T (pt) Tratamento da taquicardia
IL278972B (en) Methods and compositions comprising bucindolol for the treatment of atrial fibrillation
EP3119388A4 (en) Carboxy-cyclopropyl undecanol compounds for treatment of liver disease and other medical disorders
IL277141A (en) Compounds for the treatment of heart rhythm disturbances and heart failure
IL277635A (en) Preparations and methods for the treatment of catecholaminergic polymorphic ventricular tachycardia transmitted by dominant inheritance
HUE065418T2 (hu) Indolin származékok fibrózisos betegségek kezelésére és/vagy megelõzésére
EP3601565A4 (en) MIR-92 INHIBITORS IN THE TREATMENT OF HEART FAILURE
HK40061604A (en) Sulcardine administration for treatment of acute atrial fibrillation
PL3710043T3 (pl) Fgf10 do leczenia chorób serca